
    
      Forty-four (44) healthy male or female subjects will be included. Single doses of an
      experimental Nicotine medicated chewing gum 6 mg and Nicorette® Freshfruit gum 4 mg and 2 mg
      and NiQuitin™ Mint lozenge 4 mg will be administered in a standardized mode, on four separate
      treatment visits. Periods without nicotine replacement therapy, each lasting for at least 36
      hours, will separate the treatment visits. The subjects will abstain from smoking from 8 pm
      the evening before each treatment visit and until the end of each visit. Blood for
      pharmacokinetic analyses will be drawn before, and at 2, 4, 6, 8, 10, 15, 20, 30, 45, and 60
      minutes as well as at 1.5, 2, 4, 6, 8, 10, and 12 hours after, product administration.
      Subjects will be monitored to capture any adverse events that may occur.
    
  